Navidea Biopharmaceuticals, Inc. SBIR Phase II Award, September 2016
A SBIR Phase II contract was awarded to Navidea Biopharmaceuticals, Inc. in September, 2016 for $1,500,000.0 USD from the U.S. Department of Health & Human Services.
Is a
Award Amount (USD)
1,500,000
0
Date Awarded
September 1, 2016
0
End Date
May 31, 2019
0
SBIR/STTR Award Recipient
Contract Number (US Government)
4R44CA192859-02
0
Award Phase
Phase II
0
Award Type
SBIR
0
Official Website
Find more entities like Navidea Biopharmaceuticals, Inc. SBIR Phase II Award, September 2016
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.